Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1964 Sep 1;120(3):467–490. doi: 10.1084/jem.120.3.467

THE ANTICOAGULANT AND ANTILYMPHOMA PROPERTIES OF ARSENIC AZOPROTEINS

II. COMBINATION OF ARSENIC AZOPROTEINS WITH FIBRINOGEN AND POLYMERIZING FIBRIN IN VITRO: ALTERATIONS IN MITOSIS OF LYMPHOMA 6C3HED CELLS INDUCED IN VIVO WITH ARSENIC AZOPROTEINS: DISCUSSION OF MEANS WHEREBY ARSENIC AZOPROTEINS MAY ACT UPON LYMPHOMA 6C3HED CELLS IN VIVO

J D Broome 1, John G Kidd 1
PMCID: PMC2137768  PMID: 19867292

Abstract

Experiments here given show that 4-arsonophenylazoproteins form complexes with fibrinogen which are resistant to the enzymic action of thrombin, coagulation being thus inhibited; also that arsenic azoproteins combine strongly with polymerizing fibrin, the reaction leading uniquely to acceleration of the process. Ordinary arsenicals have little or no effect on the proliferation of Lymphoma 6C3HED cells in vivo. 4-Arsonophenylazoproteins, by contrast, are strongly inhibitory, and they arrest the process of mitosis in metaphase, as does colchicine. Considered together with the observations of the preceding paper, the findings suggest that 4-arsonophenylazoproteins may exert their anticoagulant and antilymphoma effects by similar or related means: in the former instance, by combining in vitro with fibrinogen and polymerizing fibrin, thus altering the clotting process as mentioned above; and in the latter instance by combining, perhaps in a similar way, with polymerizing proteins in the mitotic spindle of proliferating Lymphoma 6C3HED cells, thus arresting mitosis. Further implications of the findings are discussed.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBERTY R. A. A study of the variation of the average isoelectric points of several plasma proteins with ionic strength. J Phys Colloid Chem. 1949 Jan;53(1):114–126. [PubMed] [Google Scholar]
  2. BASS A. D., PROBERT C. Response of a transplantable lymphosarcoma to colchicine. Cancer Res. 1950 Jul;10(7):420–422. [PubMed] [Google Scholar]
  3. CASPARY E. A. Studies on the acetylation of human fibrinogen. Biochem J. 1956 Mar;62(3):507–512. doi: 10.1042/bj0620507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HENDERSON J. F., LEPAGE G. A. Utilization of host protein by 6C3HED ascites lymphosarcoma in C3H and Swiss mice. Cancer Res. 1959 Aug;19:749–756. [PubMed] [Google Scholar]
  5. JENSEN E. V. Sulfhydryl-disulfide interchange. Science. 1959 Nov 13;130(3385):1319–1323. doi: 10.1126/science.130.3385.1319. [DOI] [PubMed] [Google Scholar]
  6. KANE R. E., HERSH R. T. The isolation and preliminary characterization of a major soluble protein of the sea urchin egg. Exp Cell Res. 1959 Jan;16(1):59–69. doi: 10.1016/0014-4827(59)90195-8. [DOI] [PubMed] [Google Scholar]
  7. KIDD J. G. Effects of arsenic-azoproteins on mouse lymphoma cells in vivo; with observations on the effects of other anti-lymphoma agents, and on the susceptibility to these effects of lymphoma cells of various types. J Exp Med. 1958 Nov 1;108(5):665–684. doi: 10.1084/jem.108.5.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LAKI K. The polymerization of proteins; the action of thrombin on fibrinogen. Arch Biochem Biophys. 1951 Jul;32(2):317–324. doi: 10.1016/0003-9861(51)90277-9. [DOI] [PubMed] [Google Scholar]
  9. MAZIA D., MITCHISON J. M., MEDINA H., HARRIS P. The direct isolation of the mitotic apparatus. J Biophys Biochem Cytol. 1961 Aug;10:467–474. doi: 10.1083/jcb.10.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MEGO J. L., McQUEEN J. D. The uptake of As74-labeled arsonoazoproteins in tissues of tumor-bearing mice. Cancer Res. 1963 May;23:523–530. [PubMed] [Google Scholar]
  11. McMASTER P. D., KRUSE H. The persistence in mice of certain foreign proteins and azoprotein tracer-antigens derived from them. J Exp Med. 1951 Oct;94(4):323–346. doi: 10.1084/jem.94.4.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. SHERRY S., TROLL W. The action of thrombin on synthetic substrates. J Biol Chem. 1954 May;208(1):95–105. [PubMed] [Google Scholar]
  13. STOERK H. C. Desoxypyridoxine observations in "acute pyridoxine deficiency". Ann N Y Acad Sci. 1950 Jul 7;52(8):1302–1317. doi: 10.1111/j.1749-6632.1950.tb54031.x. [DOI] [PubMed] [Google Scholar]
  14. THOMAS L., SMITH R. T., VON KORFF R. Cold-precipitation by heparin of a protein in rabbit and human plasma. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):813–818. doi: 10.3181/00379727-86-21241. [DOI] [PubMed] [Google Scholar]
  15. Terry B. T. DIFFERENT AMOUNTS OF TRANSFORMED ATOXYL PRODUCED BY INCUBATING ONE PER CENT. AND TEN PER CENT. ATOXYL IN BLOOD. J Exp Med. 1915 Mar 1;21(3):258–266. doi: 10.1084/jem.21.3.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. WENT H. A. Studies on the mitotic apparatus of the sea urchin by means of antigen-antibody reactions in agar. J Biophys Biochem Cytol. 1959 Dec;6:447–455. doi: 10.1083/jcb.6.3.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Waugh D. F., Livingstone B. J. Clotting Time and Reaction Velocity in the Interaction of Bovine Fibrinogen and Thrombin. Science. 1951 Feb 2;113(2927):121–124. doi: 10.1126/science.113.2927.121. [DOI] [PubMed] [Google Scholar]
  18. ZIMMERMAN A. M. Physico-chemical analysis of the isolated mitotic apparatus. Exp Cell Res. 1960 Sep;20:529–547. doi: 10.1016/0014-4827(60)90122-1. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES